. "Attachment 4. Diagnostic Classifier – Gaining Confidence Through Validation." Validation of Toxicogenomic Technologies: A Workshop Summary. Washington, DC: The National Academies Press, 2007.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Validation of Toxicogenomic Technologies: A Workshop Summary
validation on each of pseudo data sets to generate a null distribution, i.e., the distribution of prediction accuracy from all classifiers developed on all pseudo data sets. The null distribution can then be compared with the distribution of multiple 10-fold cross-validation results derived from the real data set. The degree of chance correlation in prediction can be estimated from the overlap of the two distributions.
Figure 4-4 shows the results of a test for chance correlation of a DF classifier to predict the prostate cancer. The distribution of prediction accuracy of the real data set centers around 95% while the pseudo data sets are near 50%. The real data set has a much narrower distribution compared to the pseudo data sets, indicating that the classifiers generated from the cross-validation procedure for the real data set give consistent and high prediction accuracy. In contrast, as expected, the prediction results for the pseudo data sets varied widely, implying a large variability of signal/noise ratio across these pseudo classifiers. Importantly, there is no overlap between two distributions, indicating that a statistically and biologically relevant DF classifier can be obtained using the real data set.
FIGURE 4-4 Prediction distribution in 2,000 runs of 10-fold cross-validation process: (A) real data set and (B) 2,000 pseudo data set generated from a randomization test. Source: Tong et al. 2004.